Home › Funds › Kynam Capital Management, LP › SMMT
Kynam Capital Management, LP position in SMMT
SUMMIT THERAPEUTICS INC · Health Care
Kynam Capital Management, LP reported holding 3,000,000 shares of SMMT (SUMMIT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$50.7M, representing 2.81% of its reported portfolio and ranking #13 among its reported holdings. Kynam Capital Management, LP has disclosed SMMT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Kynam Capital Management, LP's SMMT position evolved
Kynam Capital Management, LP first disclosed a stake in SMMT in Q2 2026 at 1,200,000 shares (US$17.5M). The position peaked in Q3 2026 at 3,000,000 shares, worth US$50.7M. Across 2 filings, Kynam Capital Management, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,000,000 shares valued at US$50.7M — an increase of 1,800,000 shares quarter over quarter.. Notable position changes include a 150% increase in Q3 2026 (shares fell 16% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.20M | $17.48M | New |
| Q3 2026 | 3.00M | $50.73M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SMMT and 13F data
SMMT (SUMMIT THERAPEUTICS INC) is a Health Care company. 51 other funds we track also report a position in SMMT — the largest reported positions include BAKER BROS. ADVISORS LP (US$477.7M), Affinity Asset Advisors, LLC (US$28.7M), Octagon Capital Advisors LP (US$18.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SMMT
- BAKER BROS. ADVISORS LP 32.79M sh · $477.70M · Q2 2026
- Affinity Asset Advisors, LLC 1.70M sh · $28.75M · Q3 2026
- Octagon Capital Advisors LP 1.25M sh · $18.21M · Q2 2026
- Logos Global Management LP 1.00M sh · $16.91M · Q3 2026
- GMT CAPITAL CORP 760.80K sh · $12.87M · Q3 2026
- Rock Springs Capital Management LP 715.00K sh · $12.09M · Q3 2026
- Eversept Partners, LP 526.65K sh · $8.91M · Q3 2026
- Simplify Asset Management Inc. 510.11K sh · $8.63M · Q3 2026
- First Turn Management, LLC 501.72K sh · $8.48M · Q3 2026
- HOHIMER WEALTH MANAGEMENT, LLC 441.65K sh · $7.47M · Q3 2026
- Elmind Capital, LP 493.82K sh · $7.19M · Q2 2026
More on Kynam Capital Management, LP
FAQ
How long has Kynam Capital Management, LP held SMMT?
Kynam Capital Management, LP has disclosed SMMT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Kynam Capital Management, LP's current position in SMMT?
As of Q3 2026, Kynam Capital Management, LP holds 3.00M shares of SMMT (SUMMIT THERAPEUTICS INC), valued at $50.73M, representing 2.81% of its reported portfolio and ranking #13.
Has Kynam Capital Management, LP been buying or selling SMMT?
In the latest 13F filing (Q3 2026), Kynam Capital Management, LP increased its position in SMMT. The position peaked in Q3 2026 at 3.00M shares.
Which other funds hold SMMT?
Other major institutional holders of SMMT include BAKER BROS. ADVISORS LP, Affinity Asset Advisors, LLC, Octagon Capital Advisors LP, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.